Advertisement

Short-Term and Long-Term Outcomes After Polytetrafluoroethylene-Covered Stent Implantation for the Treatment of Coronary Perforation

Published:October 02, 2015DOI:https://doi.org/10.1016/j.amjcard.2015.09.019
      This study sought to evaluate the short-term and 3-year outcomes of polytetrafluoroethylene-covered stent (PCS) for patients with coronary perforation. Implantation of a PCS has improved the immediate clinical outcomes of patients with coronary perforation. However, there are few reports regarding long-term outcomes. We evaluated a total of 57 patients who were treated with PCS for coronary perforation from April 2004 to March 2015 at a single high-volume center in Japan. Landmark analysis was performed at 30 days to determine short-term and long-term outcomes. Major adverse cardiac events (MACE) were defined as death, myocardial infarction, target vessel revascularization, and requirement for surgical repair. Of 285 patients who experienced coronary perforation, 57 patients (20%) were treated with PCS. The MACE rates were 28% at 30 days, 22% at 1 year, and 38% at 3 years. 30-day MACE was mainly driven by high rates of myocardial infarction (18%) and surgical repair (16%). The rates of target lesion revascularization were 8% and 12% at 1 and 3 years, respectively. Definite stent thrombosis was reported in 2 patients during the follow-up period. In conclusion, despite the relatively high incidence of MACE during early stage of follow-up, implantation of a PCS provides acceptable late clinical outcomes.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ajluni S.C.
        • Glazier S.
        • Blankenship L.
        • O'Neill W.W.
        • Safian R.D.
        Perforations after percutaneous coronary interventions: clinical, angiographic, and therapeutic observations.
        Cathet Cardiovasc Diagn. 1994; 32: 206-212
        • Dippel E.J.
        • Kereiakes D.J.
        • Tramuta D.A.
        • Broderick T.M.
        • Shimshak T.M.
        • Roth E.M.
        • Hattemer C.R.
        • Runyon J.P.
        • Whang D.D.
        • Schneider J.F.
        • Abbottsmith C.W.
        Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management.
        Catheter Cardiovasc Interv. 2001; 52: 279-286
        • Ellis S.G.
        • Ajluni S.
        • Arnold A.Z.
        • Popma J.J.
        • Bittl J.A.
        • Eigler N.L.
        • Cowley M.J.
        • Raymond R.E.
        • Safian R.D.
        • Whitlow P.L.
        Increased coronary perforation in the new device era. Incidence, classification, management, and outcome.
        Circulation. 1994; 90: 2725-2730
        • Gruberg L.
        • Pinnow E.
        • Flood R.
        • Bonnet Y.
        • Tebeica M.
        • Waksman R.
        • Satler L.F.
        • Pichard A.D.
        • Kent K.M.
        • Leon M.B.
        • Lindsay Jr., J.
        Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention.
        Am J Cardiol. 2000; 86 (A688): 680-682
        • Al-Lamee R.
        • Ielasi A.
        • Latib A.
        • Godino C.
        • Ferraro M.
        • Mussardo M.
        • Arioli F.
        • Carlino M.
        • Montorfano M.
        • Chieffo A.
        • Colombo A.
        Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation.
        JACC Cardiovasc Interv. 2011; 4: 87-95
        • Shimony A.
        • Zahger D.
        • Van Straten M.
        • Shalev A.
        • Gilutz H.
        • Ilia R.
        • Cafri C.
        Incidence, risk factors, management, and outcomes of coronary artery perforation during percutaneous coronary intervention.
        Am J Cardiol. 2009; 104: 1674-1677
        • Javaid A.
        • Buch A.N.
        • Satler L.F.
        • Kent K.M.
        • Suddath W.O.
        • Lindsay Jr., J.
        • Pichard A.D.
        • Waksman R.
        Management and outcomes of coronary artery perforation during percutaneous coronary intervention.
        Am J Cardiol. 2006; 98: 911-914
        • Roguin A.
        • Beyar R.
        Coronary perforation 2006–watch for the wire.
        J Invasive Cardiol. 2005; 17: 606-608
        • Fukutomi T.
        • Suzuki T.
        • Popma J.J.
        • Hosokawa H.
        • Yokoya K.
        • Inada T.
        • Hayase M.
        • Kondo H.
        • Ito S.
        • Suzuki S.
        • Itoh M.
        Early and late clinical outcomes following coronary perforation in patients undergoing percutaneous coronary intervention.
        Circ J. 2002; 66: 349-356
        • Holmes Jr., D.R.
        • Reeder G.S.
        • Ghazzal Z.M.
        • Bresnahan J.F.
        • King 3rd, S.B.
        • Leon M.B.
        • Litvack F.
        Coronary perforation after excimer laser coronary angioplasty: the Excimer Laser Coronary Angioplasty Registry experience.
        J Am Coll Cardiol. 1994; 23: 330-335
        • Romaguera R.
        • Waksman R.
        Covered stents for coronary perforations: is there enough evidence?.
        Catheter Cardiovasc Interv. 2011; 78: 246-253
        • Colombo A.
        • Itoh A.
        • Di Mario C.
        • Maiello L.
        • Arena V.
        • Blengino S.
        • Briati P.
        • Ferraro M.
        • Di Francesco L.
        • Martini G.
        Successful closure of a coronary vessel rupture with a vein graft stent: case report.
        Cathet Cardiovasc Diagn. 1996; 38: 172-174
        • Caputo R.P.
        • Amin N.
        • Marvasti M.
        • Wagner S.
        • Levy C.
        • Giambartolomei A.
        Successful treatment of a saphenous vein graft perforation with an autologous vein-covered stent.
        Catheter Cardiovasc Interv. 1999; 48: 382-386
        • Colombo A.
        • Almagor Y.
        • Gaspar J.
        • Vonderwalde C.
        The pericardium covered stent (PCS).
        EuroIntervention. 2009; 5: 394-399
        • Hayat S.A.
        • Ghani S.
        • More R.S.
        Treatment of ruptured coronary aneurysm with a novel covered stent.
        Catheter Cardiovasc Interv. 2009; 74: 367-370
        • Pienvichit P.
        • Waters J.
        Successful closure of coronary artery perforation using makeshift stent sandwich.
        Catheter Cardiovasc Interv. 2001; 54: 209-213
        • Gercken U.
        • Lansky A.J.
        • Buellesfeld L.
        • Desai K.
        • Badereldin M.
        • Mueller R.
        • Selbach G.
        • Leon M.B.
        • Grube E.
        Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results.
        Catheter Cardiovasc Interv. 2002; 56: 353-360
        • Briguori C.
        • Nishida T.
        • Anzuini A.
        • Di Mario C.
        • Grube E.
        • Colombo A.
        Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures.
        Circulation. 2000; 102: 3028-3031
        • Ly H.
        • Awaida J.P.
        • Lesperance J.
        • Bilodeau L.
        Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations.
        Am J Cardiol. 2005; 95: 244-246
        • Elsner M.
        • Auch-Schwelk W.
        • Britten M.
        • Walter D.H.
        • Schachinger V.
        • Zeiher A.M.
        Coronary stent grafts covered by a polytetrafluoroethylene membrane.
        Am J Cardiol. 1999; 84 (A338): 335-338
        • Schachinger V.
        • Hamm C.W.
        • Munzel T.
        • Haude M.
        • Baldus S.
        • Grube E.
        • Bonzel T.
        • Konorza T.
        • Koster R.
        • Arnold R.
        • Haase J.
        • Probst P.
        • vom Dahl J.
        • Neumann F.J.
        • Mudra H.
        • Hennen B.
        • Thiele L.
        • Zeiher A.M.
        A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts.
        J Am Coll Cardiol. 2003; 42: 1360-1369
        • Stankovic G.
        • Colombo A.
        • Presbitero P.
        • van den Branden F.
        • Inglese L.
        • Cernigliaro C.
        • Niccoli L.
        • Bartorelli A.L.
        • Rubartelli P.
        • Reifart N.
        • Heyndrickx G.R.
        • Saunamaki K.
        • Morice M.C.
        • Sgura F.A.
        • Di Mario C.
        Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial.
        Circulation. 2003; 108: 37-42
        • Stone G.W.
        • Goldberg S.
        • O'Shaughnessy C.
        • Midei M.
        • Siegel R.M.
        • Cristea E.
        • Dangas G.
        • Lansky A.J.
        • Mehran R.
        5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial.
        JACC Cardiovasc Interv. 2011; 4: 300-309
        • Copeland K.A.
        • Hopkins J.T.
        • Weintraub W.S.
        • Rahman E.
        Long-term follow-up of polytetrafluoroethylene-covered stents implanted during percutaneous coronary intervention for management of acute coronary perforation.
        Catheter Cardiovasc Interv. 2012; 80: 53-57
        • Moussa I.D.
        • Klein L.W.
        • Shah B.
        • Mehran R.
        • Mack M.J.
        • Brilakis E.S.
        • Reilly J.P.
        • Zoghbi G.
        • Holper E.
        • Stone G.W.
        Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).
        J Am Coll Cardiol. 2013; 62: 1563-1570
        • Laskey W.K.
        • Yancy C.W.
        • Maisel W.H.
        Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006.
        Circulation. 2007; 115: 2352-2357
        • Mulvihill N.T.
        • Boccalatte M.
        • Sousa P.
        • Farah B.
        • Laborde J.C.
        • Fajadet J.
        • Marco J.
        Rapid sealing of coronary perforations using polytetrafluoroethylene-covered stents.
        Am J Cardiol. 2003; 91: 343-346
        • Takano M.
        • Yamamoto M.
        • Inami T.
        • Murakami D.
        • Seino Y.
        • Mizuno K.
        Delayed healing of a coronary stent graft.
        JACC Cardiovasc Interv. 2011; 4: 466-467
        • Dolmatch B.L.
        • Tio F.O.
        • Li X.D.
        • Dong Y.H.
        Patency and tissue response related to two types of polytetrafluoroethylene-covered stents in the dog.
        J Vasc Interv Radiol. 1996; 7: 641-649